Large-Scale Clinical-Grade Retroviral Vector Production in iCELLis Nano Bioreactor

被引：0
|
作者：
Wang, Xiuyan [1 ,3 ]
Olzzewska, Malgorzata [1 ]
Qu, Jinrong [1 ]
Wasielewska, Teresa [1 ]
Bartido, Shirley [1 ]
Hermetet, Gregory [4 ]
Sadelain, Michel [2 ,3 ]
Riviere, Isabelle [1 ,2 ,3 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Cell Therapy & Cell Engn Facil, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10021 USA
[4] ATMI Life Sci, Allston, MA USA
来源：
MOLECULAR THERAPY | 2013年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
50
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [21] Towards a more economical large-scale production of clinical grade MSCs
    Valceckiene, V.
    Stoskus, M.
    Bukauskas, A.
    Griskevicius, L.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S323 - S323
  • [22] EVALUATION OF TRANSFECTION REAGENTS FOR HIGH TITER LENTIVIRUS PRODUCTION IN THE ICELLIS NANO BIOREACTOR
    Pezoa, S.
    Alfano, R.
    Hazi, N.
    CYTOTHERAPY, 2022, 24 (05) : S142 - S142
  • [23] Generation of retroviral packaging and producer cell lines for large-scale vector production and clinical application:: Improved safety and high titer
    Sheridan, PL
    Bodner, M
    Lynn, A
    Phuong, TK
    DePolo, NJ
    de la Vega, DJ
    O'Dea, J
    Nguyen, K
    McCormack, JE
    Driver, DA
    Townsend, K
    Ibañez, CE
    Sajjadi, NC
    Greengard, JS
    Moore, MD
    Respess, J
    Chang, SMW
    Dubensky, TW
    Jolly, DJ
    Sauter, SL
    MOLECULAR THERAPY, 2000, 2 (03) : 262 - 275
  • [24] Large-scale production of retroviral vectors for systemic gene delivery
    Huentelman, MJ
    Reaves, PY
    Katovich, MJ
    Raizada, MK
    GENE THERAPY METHODS, 2002, 346 : 562 - 573
  • [25] Continuous retroviral vector production in a perfusion bioreactor system
    Knoess, H
    Merget-Millitzer, H
    Schroeder, B
    ANIMAL CELL TECHNOLOGY: FROM TARGET TO MARKET, 2001, 1 : 532 - 534
  • [26] Scale-up and manufacturing of clinical-grade self-inactivating γ-retroviral vectors by transient transfection
    van der Loo, J. C. M.
    Swaney, W. P.
    Grassman, E.
    Terwilliger, A.
    Higashimoto, T.
    Schambach, A.
    Baum, C.
    Thrasher, A. J.
    Williams, D. A.
    Nordling, D. L.
    Reeves, L.
    Malik, P.
    GENE THERAPY, 2012, 19 (03) : 246 - 254
  • [27] Scale-up and manufacturing of clinical-grade self-inactivating γ-retroviral vectors by transient transfection
    J C M van der Loo
    W P Swaney
    E Grassman
    A Terwilliger
    T Higashimoto
    A Schambach
    C Baum
    A J Thrasher
    D A Williams
    D L Nordling
    L Reeves
    P Malik
    Gene Therapy, 2012, 19 : 246 - 254
  • [28] Scaling up the Lentiviral Vector Manufacturing Using iCELLis500 Clinical Scale Fixed-Bed Bioreactor
    Lipponen, Eevi M.
    Leinonen, Hanna M.
    Oruetxebarria, Igor
    Valkama, Anniina J.
    Malinen, Joonas
    Turkki, Vesa
    Laaksonen, Iina
    Pietikainen, Sanna
    Kayhty, Piia
    Heikura, Tommi
    Yla-Herttuala, Seppo
    Lesch, Hanna P.
    MOLECULAR THERAPY, 2017, 25 (05) : 224 - 224
  • [29] 10-Year stability of clinical-grade serum-free γ-retroviral vector-containing medium
    Herbst, F.
    Ball, C. R.
    Zavidij, O.
    Fessler, S.
    Schmidt, M.
    Veelken, H.
    von Kalle, C.
    Glimm, H.
    GENE THERAPY, 2011, 18 (02) : 210 - 212
  • [30] 10-Year stability of clinical-grade serum-free γ-retroviral vector-containing medium
    F Herbst
    C R Ball
    O Zavidij
    S Fessler
    M Schmidt
    H Veelken
    C von Kalle
    H Glimm
    Gene Therapy, 2011, 18 : 210 - 212
12345